RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
The COVID-19 pandemic demonstrates the ongoing threat of pandemics caused by novel, previously unrecognized, or mutated pathogens with high transmissibility. Currently, vaccine development is too slow for vaccines to be used in the control of emerging pandemics. RNA-based vaccines might be suitable...
Main Authors: | Jonas B. Sandbrink, Robin J. Shattock |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.608460/full |
Similar Items
-
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
by: Zoltán Kis, et al.
Published: (2021-12-01) -
In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?
by: Ignasi Esteban, et al.
Published: (2021-03-01) -
New Vaccine Technologies to Combat Outbreak Situations
by: Susanne Rauch, et al.
Published: (2018-09-01) -
Advances in mRNA Vaccines for Infectious Diseases
by: Cuiling Zhang, et al.
Published: (2019-03-01) -
mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection
by: Shuqin Xu, et al.
Published: (2020-09-01)